Top Senate Dem Opposes Supreme Court Pick, Vows

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone
135
Top Senate Dem Opposes Supreme Court Pick, Vows Filibuster



WASHINGTON (AP) — The top Senate Democrat said Thursday he will oppose President Donald Trump’s Supreme Court nominee and lead a filibuster of the choice, setting up a politically charged showdown with Republicans with far-reaching implications for future judicial nominees.

New York Sen. Chuck Schumer criticized Judge Neil Gorsuch, saying he “almost instinctively favors the powerful over the weak” and would not serve as a check on Trump or be a mainstream justice.

“I have concluded that I cannot support Neil Gorsuch’s nomination,” Schumer said on the Senate floor. “My vote will be no and I urge my colleagues to do the same.”

Shortly before Schumer’s announcement, Pennsylvania Sen. Bob Casey, who faces re-election next year in a state Trump won, also announced his opposition. Casey said he had “serious concerns about Judge Gorsuch’s rigid and restrictive judicial philosophy, manifest in a number of opinions he has written on the 10th Circuit.”

Democrats are still furious that Republicans blocked former President Barack Obama’s nominee, Merrick Garland, and the seat on the high court has remained vacant for 13 months and counting. The GOP insisted that the next president make the nomination.

Liberals have pressured Democrats to resist all things Trump, including his nominees, although Gorsuch emerged unscathed from two days of testifying.

Senate Majority Leader Mitch McConnell, R-Ky., now must decide whether to take the same step his Democratic predecessor did and change Senate rules to confirm Gorsuch and other Supreme Court nominees with a simple majority rather than the 60 votes now required to move forward.

“Gorsuch will be confirmed; I just can’t tell you exactly how that will happen, yet,” McConnell said in an interview with The Associated Press earlier this week.

The Judiciary panel is expected to vote in the next two weeks to recommend Gorsuch favorably to the full Senate.

Democrats Jeff Merkley of Oregon, Kirsten Gillibrand of New York, Sherrod Brown of Ohio, Tammy Baldwin of Wisconsin, Elizabeth Warren of Massachusetts and Ed Markey of Massachusetts have declared their opposition.

No Democrat has yet pledged to support the judge, but Sen. Joe Manchin of West Virginia said Wednesday he is open to voting for him.

Hearings for a Supreme Court nominee usually dominate Congress, but that’s not been the case over the four days of hearings. The Republican push to dismantle Obama’s Affordable Care Act and the controversy surrounding the investigation into contact between Trump associates and Russia overshadowed the hearings.

On Thursday, lawyers, advocacy groups and former colleagues got their say on Gorsuch during the third and likely final hearing examining his qualifications.

The American Bar Association’s Nancy Scott Degan explained how a committee evaluating Gorsuch came up with its highest rating of well qualified. She said the committee contacted almost 5,000 people nationwide who might have knowledge of his qualifications. They examined his qualifications based on integrity, professional competence and temperament.

“The scope of our investigation was deep and broad,” Degan said. “We do not give the well-qualified rating lightly.”

Sen. Dianne Feinstein, D-Calif., also noted that Garland received the ABA’s well-qualified rating, but didn’t get a hearing. Republican Sen. Orrin Hatch of Utah said he agreed that Garland is a wonderful person and well qualified.

The panel heard from several supporters and critics of Gorsuch.

Retired U.S. Court of Appeals Judge Deanell Reece Tacha served with Gorsuch and said he brings to the bench a powerful intellect and does not use his role as judge for anything other than deciding the case before him.

Some witnesses who were critical of Gorsuch worried that he would not be a strong check on executive overreach. Elisa Massimino, president and CEO of Human Rights First, described him as someone “who wouldn’t stand up against a presidential power grab,” stemming from his service in the Justice Department during the Bush administration.

[url=WASHINGTON (AP) — The top Senate Democrat said Thursday he will oppose President Donald Trump’s Supreme Court nominee and lead a filibuster of the choice, setting up a politically charged showdown with Republicans with far-reaching implications for future judicial nominees.

New York Sen. Chuck Schumer criticized Judge Neil Gorsuch, saying he “almost instinctively favors the powerful over the weak” and would not serve as a check on Trump or be a mainstream justice.

“I have concluded that I cannot support Neil Gorsuch’s nomination,” Schumer said on the Senate floor. “My vote will be no and I urge my colleagues to do the same.”

Shortly before Schumer’s announcement, Pennsylvania Sen. Bob Casey, who faces re-election next year in a state Trump won, also announced his opposition. Casey said he had “serious concerns about Judge Gorsuch’s rigid and restrictive judicial philosophy, manifest in a number of opinions he has written on the 10th Circuit.”

Democrats are still furious that Republicans blocked former President Barack Obama’s nominee, Merrick Garland, and the seat on the high court has remained vacant for 13 months and counting. The GOP insisted that the next president make the nomination.

Liberals have pressured Democrats to resist all things Trump, including his nominees, although Gorsuch emerged unscathed from two days of testifying.

Senate Majority Leader Mitch McConnell, R-Ky., now must decide whether to take the same step his Democratic predecessor did and change Senate rules to confirm Gorsuch and other Supreme Court nominees with a simple majority rather than the 60 votes now required to move forward.

“Gorsuch will be confirmed; I just can’t tell you exactly how that will happen, yet,” McConnell said in an interview with The Associated Press earlier this week.

The Judiciary panel is expected to vote in the next two weeks to recommend Gorsuch favorably to the full Senate.

Democrats Jeff Merkley of Oregon, Kirsten Gillibrand of New York, Sherrod Brown of Ohio, Tammy Baldwin of Wisconsin, Elizabeth Warren of Massachusetts and Ed Markey of Massachusetts have declared their opposition.

No Democrat has yet pledged to support the judge, but Sen. Joe Manchin of West Virginia said Wednesday he is open to voting for him.

Hearings for a Supreme Court nominee usually dominate Congress, but that’s not been the case over the four days of hearings. The Republican push to dismantle Obama’s Affordable Care Act and the controversy surrounding the investigation into contact between Trump associates and Russia overshadowed the hearings.

On Thursday, lawyers, advocacy groups and former colleagues got their say on Gorsuch during the third and likely final hearing examining his qualifications.

The American Bar Association’s Nancy Scott Degan explained how a committee evaluating Gorsuch came up with its highest rating of well qualified. She said the committee contacted almost 5,000 people nationwide who might have knowledge of his qualifications. They examined his qualifications based on integrity, professional competence and temperament.

“The scope of our investigation was deep and broad,” Degan said. “We do not give the well-qualified rating lightly.”

Sen. Dianne Feinstein, D-Calif., also noted that Garland received the ABA’s well-qualified rating, but didn’t get a hearing. Republican Sen. Orrin Hatch of Utah said he agreed that Garland is a wonderful person and well qualified.

The panel heard from several supporters and critics of Gorsuch.

Retired U.S. Court of Appeals Judge Deanell Reece Tacha served with Gorsuch and said he brings to the bench a powerful intellect and does not use his role as judge for anything other than deciding the case before him.

Some witnesses who were critical of Gorsuch worried that he would not be a strong check on executive overreach. Elisa Massimino, president and CEO of Human Rights First, described him as someone “who wouldn’t stand up against a presidential power grab,” stemming from his service in the Justice Department during the Bush administration.]< >[/url]
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Virse Revolutionizes Creative Production with AI Canvas

Updated Category News Views 156

A New Era in Creative Workflows These days, the design world is getting a major shake-up thanks to Virse's innovative AI-driven workspace. Based out of Dover, this new system isn't just about boosting tech for the sake of it; it's about making creative production a symphony rather than a cacophony. And, let me tell ya, any time I've loaded up on coffee to prep for a brand...

Continue Reading
MPLX Reports Q3 2026 Results with 12.5% Distribution Hike

Updated Category News Views 34

Another Distribution Hike: 12.5% Bump in Q3 Man, MPLX is at it again, boosting that quarterly distribution by a hefty 12.5%. That's three years running now, marking it up to $4.84 per unit on an annualized basis. In an industry where reliability sometimes feels like a relic, this kind of consistency is a sweet serenade to any income-focused investor's ears. "MPLX is...

Continue Reading
Newcomers, Veterans Elevate NYSE's Tokenization Efforts

Updated Category News Views 100

Breaking New Ground at the NYSE When the bell rings at the NYSE these days, it's not just marking the start of another trading session. It's the sound of change clanging its way onto Wall Street. On November 3, 2026, the NYSE threw its hat deeper into the tokenization ring, a game-changer perhaps. They've roped in some big guns—Securitize, tZERO, Broadridge Financial...

Continue Reading
Lupin Launches HIV Treatment, Secures 180-Day Exclusivity

Updated Category News Views 18

Lupin's Market Move: A Big Step in HIV Treatment There's a fresh gust blowing in the pharmaceutical skies today, as Lupin leaps ahead with the launch of their Raltegravir Tablets in the U.S. The company just bagged FDA approval, putting them on the front lines with a high-stake 180-day exclusivity period for their generic version. For investors keeping tabs on pharma...

Continue Reading
Canton Fair Showcases Cutting-Edge Healthcare Tech 2026

Updated Category News Views 41

Innovation Steals the Show in Guangzhou In a world where tech evolution rarely takes a breather, the 140th Canton Fair's Intelligent Healthcare Zone is like a breath of fresh air. Picture it: a whole arena pulsing with futuristic healthcare gizmos from October 31 to November 4, 2026—it's as if tomorrow swung by for a sneak peek. The event brings together everything from...

Continue Reading
Yunji Rolls Out AI Robots at EquipHotel Paris 2026

Updated Category News Views 90

AI Takes Center Stage in Hospitality When someone mentions a new revolution in hospitality, I usually roll my eyes. But this time, Yunji Technology (HKEX: 02670) is bringing something to the table that's hard to ignore. They’re out in full force at EquipHotel Paris 2026, flaunting their AI-powered collection of service bots with the kind of confidence that says, 'We're...

Continue Reading
Reju Partners with Six Mills to Advance Textile Regeneration

Updated Category News Views 203

Big Moves in Textile Regeneration Now here's a move that's got the fabric world buzzing: Reju, the scrappy textile-to-textile regenerative powerhouse, is teaming up with six mills spread across Europe and the U.S. They’re setting the stage to crank up their polyester recycling game and flood the market with sustainable, eco-friendly fabrics. It's a bold step toward...

Continue Reading
Himel's Latest: Powering Industry and Homes Alike

Updated Category News Views 46

Switching Gears: Himel's New Electrical Frontiers Ah, the humming of motors, the click of switches—it's the backbone of any decent industrial setup or modern home today. Himel isn't messing around when it comes to staying on top of these evolving electrical needs, both in gritty industrial settings and our cozy living rooms. This time, they're taking a serious crack at...

Continue Reading
XPENG Eyes South Korea Entry with Industry Veteran

Updated Category News Views 142

A Veteran's Task in a New Territory Piling onto its international ambitions, XPENG has roped in Lee Man-sik, a seasoned auto industry professional, to break into South Korea. South Korea isn’t just another market—it’s one of the toughest stages for the automotive industry. The customers there are sharp, with a keen eye for tech and quality. So XPENG, trading under...

Continue Reading
Samsung Biologics Hits 'Negligible' ESG Risk Milestone

Updated Category News Views 26

Samsung Biologics Achieves a Low-Risk Triumph You gotta hand it to Samsung Biologics for hitting a 'Negligible Risk' rating. Their latest score? A cool 9.0. That’s like walking into the pharmaceuticals room and getting a standing ovation. It's no small feat—climbing up from a 'Low Risk' rating to the top tier in Morningstar Sustainalytics' playbook. For us spectating...

Continue Reading

Top 5 Most Recently Viewed Articles

Deutsche Bank's Optimism for Monster Beverage's Future Growth

Updated Category News Views 287

Positive Outlook for Monster Beverage (NASDAQ:MNST) Deutsche Bank has reiterated its optimistic outlook on Monster Beverage, maintaining a Buy rating with a consistent price target of $61. This affirmation comes as the company is poised to announce its third-quarter earnings, which are expected to meet market forecasts, albeit with slightly cautious revenue expectations....

Continue Reading
Ideal Living Unveils Smart AquaTru Carafe for Clean Water Access

Updated Category News Views 308

Introducing AquaTru Carafe Smart: A New Era of Water Purification Ideal Living has taken a pioneering step in ensuring that everyone can have access to pure, clean water with the launch of the AquaTru Carafe Smart. This innovative product is not just a water purifier; it’s a smart device designed to keep you informed about your water quality, ensuring safer drinking...

Continue Reading
Interface's Q4 Earnings: A Closer Look at TILE's Performance

Updated Category News Views 192

Analyzing Interface's Q4 Earnings Interface (NASDAQ:TILE) rolled out its Q4 earnings report on February 24, 2026, and let me tell you, there’s buzz in the air. They posted an EPS of $0.49, beating expectations by a solid 22.5%. Now, that’s the kind of surprise that can make a market jump. They also got revenue up by $14.38 million since this time last year—people...

Continue Reading
Unveiling Innovations at Telematics & Connected Mobility 2025

Updated Category News Views 277

Exploring the Future at Telematics & Connected Mobility 2025 Gurtam is excited to announce its flagship event, Telematics & Connected Mobility 2025, taking place in early September. This two-day event will gather a diverse group of participants, including fleet operators, telematics service providers, industry experts, and innovative hardware manufacturers. The goal is to...

Continue Reading
Codexis Provides New Grants to Enhance Talent Acquisition

Updated Category News Views 114

Codexis Announces New Employment Inducement Grants Today, Codexis, Inc. (NASDAQ: CDXS), a prominent player in the field of enzymatic solutions, made headlines with its announcement regarding new employment inducement grants. This move illustrates Codexis' commitment to recruiting top-tier talent, essential for their continuous growth and innovation. Details of the...

Continue Reading